Embolic Protection Devices
Oct 30, 2025
Zimmer Biomet Wins FDA Breakthrough Status for Iodine-Treated Hip Implant; Terumo Gains U.S. Clearance for OPUSWAVE® System and DualView® Catheter; Medtronic’s Symplicity Spyral RDN Device Added to CMS National Coverage; West Launches Synchrony™ PFS System at CPHI; Emboline Completes U.S. Pivotal IDE Trial Enrollment for Emboliner® Device; Laborie Completes First Procedures in ENDURE 1 Trial with Optilume® Balloon
Zimmer Biomet Announced FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System On October 28, 2025, Zimmer Biomet Holdings, Inc., a global leader in medical technology, announced that the FDA had granted breakthrough device designation for its groundbreaking iodine-treat...
Read More...
Nov 02, 2023
Laborie Medical Acquired Urotronic; Sirtex’s LAVA Liquid Embolic System; Paige’s Cancer Detection in Breast Lymph Nodes; FDA Clearance to Neurovalens’s Non-Invasive Insomnia-Treating Device; Recor Medical’s Renal Denervation System; Pulsecare Medical’s nsPFA Clinical Trial Short-term Follow-up Results
Neurovalens Received US FDA Clearance for Non-Invasive Insomnia-Treating Device On October 30, 2023, Belfast, Northern Ireland-based Neurovalens announced the US Food and Drug Administration clearance for its Modius Sleep device meant for treating chronic insomnia. Modius has been designed to deli...
Read More...
Jun 02, 2022
GenScript Enters Distribution Agreement with EUROIMMUN; Biomerics’s New Facility in Galway (Ireland); MedAlliance’s SELUTION SLR DEB; OmniGuide’s RevoLix HTL Hybrid Thulium Laser; Filterlex’s CAPTIS Full-Body Embolic Protection Device; Orthofix’s M6-C Artificial Cervical Disc
GenScript USA Announced the Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neutralizing Antibody Detection Kit On May 26, 2022, GenScript USA Inc., a subsidiary of GenScript Biotech Corporation and a world-leading biotechnology company, agreed with EUROIMMUN US Inc., a PerkinElmer Company, for the...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
